- Revenue Cycle Management
- COVID-19
- Reimbursement
- Diabetes Awareness Month
- Risk Management
- Patient Retention
- Staffing
- Medical Economics® 100th Anniversary
- Coding and documentation
- Business of Endocrinology
- Telehealth
- Physicians Financial News
- Cybersecurity
- Cardiovascular Clinical Consult
- Locum Tenens, brought to you by LocumLife®
- Weight Management
- Business of Women's Health
- Practice Efficiency
- Finance and Wealth
- EHRs
- Remote Patient Monitoring
- Sponsored Webinars
- Medical Technology
- Billing and collections
- Acute Pain Management
- Exclusive Content
- Value-based Care
- Business of Pediatrics
- Concierge Medicine 2.0 by Castle Connolly Private Health Partners
- Practice Growth
- Concierge Medicine
- Business of Cardiology
- Implementing the Topcon Ocular Telehealth Platform
- Malpractice
- Influenza
- Sexual Health
- Chronic Conditions
- Technology
- Legal and Policy
- Money
- Opinion
- Vaccines
- Practice Management
- Patient Relations
- Careers
Statins have wide range of unintended adverse effects
Statins appear to have no significant association with a large number of diseases, but they may have a wide range of unintended adverse effects, according to research.
BMJ. [online] May 20, 2010. http://www.bmj.com/cgi/content/abstract/340/may19_4/c2197. Accessed June 1, 2010
Statins appear to have no significant association with a large number of diseases, but they may have a wide range of unintended adverse effects, according to researchers from the University of Nottingham in the United Kingdom. They conducted a prospective open cohort study of more than 2 million patients aged 30 to 84, including 225,922 (10.7 percent) of whom were new users of statins, to quantify the unintended effects of statins according to type, dose, and duration of use. The researchers found statin use was linked to a decreased risk of esophageal cancer, but an increased risk of moderate or serious liver dysfunction, acute renal failure, moderate or serious myopathy, and cataract. The adverse effects were similar across all types of statins with the exception of liver dysfunction risk, which was highest for fluvastatin. All increased risks were highest in the first year and persisted during treatment.
